Don’t miss the latest developments in business and finance.

Concord Drugs standalone net profit declines 33.33% in the September 2018 quarter

Image
Capital Market
Last Updated : Nov 23 2018 | 11:16 AM IST

Sales rise 204.77% to Rs 11.49 crore

Net profit of Concord Drugs declined 33.33% to Rs 0.04 crore in the quarter ended September 2018 as against Rs 0.06 crore during the previous quarter ended September 2017. Sales rose 204.77% to Rs 11.49 crore in the quarter ended September 2018 as against Rs 3.77 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales11.493.77 205 OPM %8.4425.46 -PBDT0.600.66 -9 PBT0.050.09 -44 NP0.040.06 -33

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Nov 23 2018 | 11:01 AM IST

Next Story